NCT00983905View on ClinicalTrials.gov

Drug-Drug Interaction Study of Colchicine and Theophylline

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Pharmacokinetics
Interventions
DRUG

Theophylline

single doses of 300 mg (80 mg/15 ml elixer) administered alone at 7:45 am on Day 1 and then along with colchicine at 7:45 am on Day 19

DRUG

Colchicine

one 0.6 mg tablet twice daily at 7:45 am and 7:45 pm on Days 5 to 19

Trial Locations (1)

58104

PRACS Institute, Ltd. - Cetero Research, Fargo

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00983905 - Drug-Drug Interaction Study of Colchicine and Theophylline | Biotech Hunter | Biotech Hunter